N-[3-[[(6aS)-2-methoxy-11-oxo-8-(tritiomethylidene)-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aR)-2-methyl-11-oxo-8-(tritiomethylidene)-6,6a,7,9-tetrahydro-5H-pyrrolo[1,2-b][2]benzazepin-3-yl]oxymethyl]phenyl]-3-methoxy-N-(2-methyl-2-methylsulfanylpropyl)propanamide

C46H54N4O7S — CID 147724156

IUPACN-[3-[[(6aS)-2-methoxy-11-oxo-8-(tritiomethylidene)-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aR)-2-methyl-11-oxo-8-(tritiomethylidene)-6,6a,7,9-tetrahydro-5H-pyrrolo[1,2-b][2]benzazepin-3-yl]oxymethyl]phenyl]-3-methoxy-N-(2-methyl-2-methylsulfanylpropyl)propanamide
SMILES[3H]/C=C1\C[C@H]2CCc3cc(OCc4cc(COc5cc6c(cc5OC)C(=O)N5C/C(=C/[3H])C[C@H]5C=N6)cc(N(CC(C)(C)SC)C(=O)CCOC)c4)c(C)cc3C(=O)N2C1
InChIInChI=1S/C46H54N4O7S/c1-28-13-34-10-9-33-19-40(30(3)15-37(33)44(52)48(34)23-28)56-25-31-16-32(18-35(17-31)50(27-46(4,5)58-8)43(51)11-12-54-6)26-57-42-21-39-38(20-41(42)55-7)45(53)49-24-29(2)14-36(49)22-47-39/h15-22,34,36H,1-2,9-14,23-27H2,3-8H3/t34-,36+/m1/s1/i1T,2T/b28-1+,29-2+
InChIKeyGXDNEONOYMTXHM-NKIDADOFSA-N
MW811.04 g/mol
LogP7.88
Rot. Bonds14

About N-[3-[[(6aS)-2-methoxy-11-oxo-8-(tritiomethylidene)-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aR)-2-methyl-11-oxo-8-(tritiomethylidene)-6,6a,7,9-tetrahydro-5H-pyrrolo[1,2-b][2]benzazepin-3-yl]oxymethyl]phenyl]-3-methoxy-N-(2-methyl-2-methylsulfanylpropyl)propanamide

N-[3-[[(6aS)-2-methoxy-11-oxo-8-(tritiomethylidene)-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aR)-2-methyl-11-oxo-8-(tritiomethylidene)-6,6a,7,9-tetrahydro-5H-pyrrolo[1,2-b][2]benzazepin-3-yl]oxymethyl]phenyl]-3-methoxy-N-(2-methyl-2-methylsulfanylpropyl)propanamide (PubChem CID 147724156) has the molecular formula C46H54N4O7S and a molecular weight of 811.04 g/mol. Its IUPAC name is N-[3-[[(6aS)-2-methoxy-11-oxo-8-(tritiomethylidene)-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aR)-2-methyl-11-oxo-8-(tritiomethylidene)-6,6a,7,9-tetrahydro-5H-pyrrolo[1,2-b][2]benzazepin-3-yl]oxymethyl]phenyl]-3-methoxy-N-(2-methyl-2-methylsulfanylpropyl)propanamide.

Molecular Properties

Compound NameN-[3-[[(6aS)-2-methoxy-11-oxo-8-(tritiomethylidene)-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aR)-2-methyl-11-oxo-8-(tritiomethylidene)-6,6a,7,9-tetrahydro-5H-pyrrolo[1,2-b][2]benzazepin-3-yl]oxymethyl]phenyl]-3-methoxy-N-(2-methyl-2-methylsulfanylpropyl)propanamide
PubChem CID147724156
Molecular FormulaC46H54N4O7S
Molecular Weight811.04 g/mol
Exact Mass810.39
IUPAC NameN-[3-[[(6aS)-2-methoxy-11-oxo-8-(tritiomethylidene)-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aR)-2-methyl-11-oxo-8-(tritiomethylidene)-6,6a,7,9-tetrahydro-5H-pyrrolo[1,2-b][2]benzazepin-3-yl]oxymethyl]phenyl]-3-methoxy-N-(2-methyl-2-methylsulfanylpropyl)propanamide
SMILES[3H]/C=C1\C[C@H]2CCc3cc(OCc4cc(COc5cc6c(cc5OC)C(=O)N5C/C(=C/[3H])C[C@H]5C=N6)cc(N(CC(C)(C)SC)C(=O)CCOC)c4)c(C)cc3C(=O)N2C1
InChIInChI=1S/C46H54N4O7S/c1-28-13-34-10-9-33-19-40(30(3)15-37(33)44(52)48(34)23-28)56-25-31-16-32(18-35(17-31)50(27-46(4,5)58-8)43(51)11-12-54-6)26-57-42-21-39-38(20-41(42)55-7)45(53)49-24-29(2)14-36(49)22-47-39/h15-22,34,36H,1-2,9-14,23-27H2,3-8H3/t34-,36+/m1/s1/i1T,2T/b28-1+,29-2+
InChIKeyGXDNEONOYMTXHM-NKIDADOFSA-N
XLogP7.88
TPSA110.21 Ų
H-Bond Donors
H-Bond Acceptors9
Rotatable Bonds14
Heavy Atoms58
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500811.04
LogP ≤ 57.88
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze N-[3-[[(6aS)-2-methoxy-11-oxo-8-(tritiomethylidene)-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aR)-2-methyl-11-oxo-8-(tritiomethylidene)-6,6a,7,9-tetrahydro-5H-pyrrolo[1,2-b][2]benzazepin-3-yl]oxymethyl]phenyl]-3-methoxy-N-(2-methyl-2-methylsulfanylpropyl)propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-[[(6aS)-2-methoxy-11-oxo-8-(tritiomethylidene)-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aR)-2-methyl-11-oxo-8-(tritiomethylidene)-6,6a,7,9-tetrahydro-5H-pyrrolo[1,2-b][2]benzazepin-3-yl]oxymethyl]phenyl]-3-methoxy-N-(2-methyl-2-methylsulfanylpropyl)propanamide?
The IUPAC name of N-[3-[[(6aS)-2-methoxy-11-oxo-8-(tritiomethylidene)-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aR)-2-methyl-11-oxo-8-(tritiomethylidene)-6,6a,7,9-tetrahydro-5H-pyrrolo[1,2-b][2]benzazepin-3-yl]oxymethyl]phenyl]-3-methoxy-N-(2-methyl-2-methylsulfanylpropyl)propanamide (CID 147724156) is N-[3-[[(6aS)-2-methoxy-11-oxo-8-(tritiomethylidene)-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aR)-2-methyl-11-oxo-8-(tritiomethylidene)-6,6a,7,9-tetrahydro-5H-pyrrolo[1,2-b][2]benzazepin-3-yl]oxymethyl]phenyl]-3-methoxy-N-(2-methyl-2-methylsulfanylpropyl)propanamide.
What is the SMILES notation for N-[3-[[(6aS)-2-methoxy-11-oxo-8-(tritiomethylidene)-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aR)-2-methyl-11-oxo-8-(tritiomethylidene)-6,6a,7,9-tetrahydro-5H-pyrrolo[1,2-b][2]benzazepin-3-yl]oxymethyl]phenyl]-3-methoxy-N-(2-methyl-2-methylsulfanylpropyl)propanamide?
The canonical SMILES for N-[3-[[(6aS)-2-methoxy-11-oxo-8-(tritiomethylidene)-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aR)-2-methyl-11-oxo-8-(tritiomethylidene)-6,6a,7,9-tetrahydro-5H-pyrrolo[1,2-b][2]benzazepin-3-yl]oxymethyl]phenyl]-3-methoxy-N-(2-methyl-2-methylsulfanylpropyl)propanamide is [3H]/C=C1\C[C@H]2CCc3cc(OCc4cc(COc5cc6c(cc5OC)C(=O)N5C/C(=C/[3H])C[C@H]5C=N6)cc(N(CC(C)(C)SC)C(=O)CCOC)c4)c(C)cc3C(=O)N2C1.
What is the InChIKey of N-[3-[[(6aS)-2-methoxy-11-oxo-8-(tritiomethylidene)-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aR)-2-methyl-11-oxo-8-(tritiomethylidene)-6,6a,7,9-tetrahydro-5H-pyrrolo[1,2-b][2]benzazepin-3-yl]oxymethyl]phenyl]-3-methoxy-N-(2-methyl-2-methylsulfanylpropyl)propanamide?
The InChIKey is GXDNEONOYMTXHM-NKIDADOFSA-N. The full InChI is InChI=1S/C46H54N4O7S/c1-28-13-34-10-9-33-19-40(30(3)15-37(33)44(52)48(34)23-28)56-25-31-16-32(18-35(17-31)50(27-46(4,5)58-8)43(51)11-12-54-6)26-57-42-21-39-38(20-41(42)55-7)45(53)49-24-29(2)14-36(49)22-47-39/h15-22,34,36H,1-2,9-14,23-27H2,3-8H3/t34-,36+/m1/s1/i1T,2T/b28-1+,29-2+.
What are the key properties of N-[3-[[(6aS)-2-methoxy-11-oxo-8-(tritiomethylidene)-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aR)-2-methyl-11-oxo-8-(tritiomethylidene)-6,6a,7,9-tetrahydro-5H-pyrrolo[1,2-b][2]benzazepin-3-yl]oxymethyl]phenyl]-3-methoxy-N-(2-methyl-2-methylsulfanylpropyl)propanamide?
N-[3-[[(6aS)-2-methoxy-11-oxo-8-(tritiomethylidene)-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aR)-2-methyl-11-oxo-8-(tritiomethylidene)-6,6a,7,9-tetrahydro-5H-pyrrolo[1,2-b][2]benzazepin-3-yl]oxymethyl]phenyl]-3-methoxy-N-(2-methyl-2-methylsulfanylpropyl)propanamide has a molecular weight of 811.04 g/mol, XLogP of 7.88, 14 rotatable bonds, 0 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[[(6aS)-2-methoxy-11-oxo-8-(tritiomethylidene)-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]-5-[[(6aR)-2-methyl-11-oxo-8-(tritiomethylidene)-6,6a,7,9-tetrahydro-5H-pyrrolo[1,2-b][2]benzazepin-3-yl]oxymethyl]phenyl]-3-methoxy-N-(2-methyl-2-methylsulfanylpropyl)propanamide is sourced from PubChem (CID 147724156), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).